These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5462594)

  • 1. [Absorption, distribution, excretion and metabolism of 14-hydroxydihydro-6-beta-thebainol 4-methylether (oxymethebanol)].
    Shindo H; Komai T; Nakajima E; Murata H; Yasumura A; Seki I
    Yakugaku Zasshi; 1970 Jan; 90(1):36-45. PubMed ID: 5462594
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological studies on a new specifically potent antitussive agent, 14-hydroxydihydro-6 beta-thebainol-4-methylether (oxymethebanol).
    Kobayashi S; Hasegawa K; Mori M; Takagi H
    Arzneimittelforschung; 1970 Jan; 20(1):43-6. PubMed ID: 5467447
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism and excretion of tritiated dextromethorphan by the rat.
    Kamm JJ; Taddeo AB; Van Loon EJ
    J Pharmacol Exp Ther; 1967 Dec; 158(3):437-44. PubMed ID: 6073227
    [No Abstract]   [Full Text] [Related]  

  • 4. The distribution and metabolic fate of xyloxemine hydrochloride in mice and rats.
    Hespe W; Prins H; Kafoe WF; Nauta WT
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):397-408. PubMed ID: 6076587
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological studies of a new potent antitussive agent, 14-hydroxy-dihydro-6 beta-thebainol-4-methyl ether (oxymethebanol)].
    Takagi H; Kobayashi S; Kumakura S; Mori M; Koike H
    Nihon Yakurigaku Zasshi; 1969 Mar; 65(2):120-45. PubMed ID: 4390383
    [No Abstract]   [Full Text] [Related]  

  • 6. [Excretion and metabolic pattern of fominoben in the urine and feces of man rabbit, dog, and rat].
    Zimmer A
    Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:317-9. PubMed ID: 4740108
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the metabolism of 1-methyl-3-[di(2-thienyl)-methylene]piperidine citrate. II].
    Sasaki Y; Sugihara J; Watanabe A; Sakuma M; Otsuka M
    Yakugaku Zasshi; 1969 Mar; 89(3):345-53. PubMed ID: 5815794
    [No Abstract]   [Full Text] [Related]  

  • 8. Dinemorphan N-demethylation by mouse liver microsomes.
    Gervasi PG; Benetti D; Citti L; Del Monte M; Turchi G
    Experientia; 1984 Feb; 40(2):180-2. PubMed ID: 6698172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of two different glucuronide metabolites of naloxone from the urine of rabbit and chicken.
    Fujimoto JM
    J Pharmacol Exp Ther; 1969 Jul; 168(1):180-6. PubMed ID: 5792680
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolic fate of Eprazinone hydrochloride. I. Absorption, distribution, and excretion of Eprazinone hydrochloride in vivo (author's transl)].
    Takanashi S; Hinoara Y; Toira Y; Kamiyama H; Suzuki H
    Yakugaku Zasshi; 1975 Aug; 95(8):1002-9. PubMed ID: 1237598
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thin layer chromatography in the purity test of benzonatate].
    Brantner A; Vámos J; Végh A; Simonyi I
    Acta Pharm Hung; 1969 Sep; 39(5):232-6. PubMed ID: 5356234
    [No Abstract]   [Full Text] [Related]  

  • 12. [Distribution of radioactivity in the organism and in exercretions of the rat after application of 14C-labelled 1-para-chlorophenyl-2,3-dimethyl-4--dimethylamino-butanol-2-HC1].
    Beisenherz G; Kopitar Z; Pelzer H
    Arzneimittelforschung; 1969 Jan; 19(1):79-85. PubMed ID: 5819368
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the metabolism of 1-methyl-3-(di(2-thienyl)methylene)piperidine citrate. I. Fractional determination of 1-methyl-3-(di(2-thienyl)methylene)piperidine and its N-demethylated derivative].
    Watanabe A; Sasaki Y; Sugihara Z; Tsuruoka M
    Yakugaku Zasshi; 1969 Jan; 89(1):29-33. PubMed ID: 5816980
    [No Abstract]   [Full Text] [Related]  

  • 14. Absorption, distribution and excretion of eprazinone in animals.
    Constantin M; Pognat JF; Streichenberger G
    Arzneimittelforschung; 1974 Nov; 24(11):1793-8. PubMed ID: 4480052
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential pharmacokinetic and metabolic profiles of the stereoisomers of 3-hydroxy-N-methyl morphinan.
    Misra AL; Vadlamani NL; Bloch R; Mule SJ
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):1-16. PubMed ID: 4811450
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences in the autoradiographic localization of labelled morphine-like analgesics in the mouse.
    Appelgren LE; Terenius L
    Acta Physiol Scand; 1973 Jun; 88(2):175-82. PubMed ID: 4202925
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thin-layer chromatographic method for the investigation of the composition of beozonatate].
    Brantner A; Vámos J; Végh A; Simonyi I
    Acta Pharm Hung; 1969 Mar; 39(2):49-53. PubMed ID: 5782920
    [No Abstract]   [Full Text] [Related]  

  • 18. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan.
    Chou YC; Liao JF; Chang WY; Lin MF; Chen CF
    Brain Res; 1999 Mar; 821(2):516-9. PubMed ID: 10064839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the metabolism of eprazinone (author's transl)].
    Toffel-Nadolny P; Gielsdorf W
    Arzneimittelforschung; 1981; 31(4):719-22. PubMed ID: 7195719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereospecific binding of narcotics to brain cerebrosides.
    Loh HH; Cho TM; Wu YC; Way EL
    Life Sci; 1974 Jun; 14(11):2231-45. PubMed ID: 4847814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.